Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
Conditions:   Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8;   Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8;   Metastatic Head and Neck Squamous Cell Carcinoma;   Metastatic Hypopharyngeal Squamous Cell Carcinoma;   Metastatic Lary ngeal Squamous Cell Carcinoma;   Metastatic Lip and Oral Cavity Carcinoma;   Metastatic Nasal Cavity Squamous Cell Carcinoma;   Metastatic Nasopharyngeal Squamous Cell Carcinoma;   Metastatic Pharyngeal Squamous Cell Carcinoma;   Metastatic Sinonasal Squamous Cell Carci noma;   Patholog...
Source: ClinicalTrials.gov - October 1, 2021 Category: Research Source Type: clinical trials